New Rapid Urine Test Could Revolutionize Treatment of UTIs

Medically reviewed by Carmen Pope, BPharm. Last updated on April 2, 2026.

via HealthDay

THURSDAY, April 2, 2026 — A new rapid urine test could lead to more targeted and effective treatment of urinary tract infections (UTI), researchers say.

It currently takes labs two to three days to determine which antibiotic would work best against an individual’s UTI.

But the new test can turn around results in just under six hours, creating the potential for same-day antibiotic prescriptions for a UTI, researchers reported in this month's issue of the Journal of Antimicrobial Chemotherapy.

“By the time the laboratory delivers the result under current methods, a patient may already have finished their antibiotics, or been given ones that do not work,” said researcher Oliver Hancox, CEO of Astratus Limited, a spin-out company of the University of Reading in the U.K.

“Being able to tell a doctor the same day which antibiotic to use means the patient gets the right treatment sooner, reducing the risk of resistance developing and their infection turning into potentially lethal sepsis,” Hancox said in a news release.

Current methods require a urine sample to be cultured overnight, so bacteria can grow to identifiable levels.

The new test uses a cartridge of fine tubes pre-loaded with different antibiotics. The cartridge is dipped into a urine sample, and optical imaging tracks bacterial growth for six hours.

If growth is blocked, the antibiotic works against that person’s infection. If not, it doesn’t.

To make sure the new test is accurate, researchers analyzed 352 urine samples from patients with suspected UTIs.

Results from the new test agreed with the current method in 97% of cases involving seven first-line antibiotics for treating UTIs.

A second study of 90 duplicate samples showed nearly 99% agreement, regardless of whether urine samples had been stored with a preservative.

"UTIs are a common reason that patients need antibiotics, and getting the right treatment first time could be a lifesaver,” said Dr. Matthew Inada-Kim, a researcher at the University of Southampton in the U.K., who was not involved in the study.

“A test that works on samples we already collect as standard, and gives us answers the same day, is exactly the kind of tool that could change how we manage these infections in practice,” he added in a news release.

Atratus Limited was founded in November 2024 by the research team behind the test. The company is working to take the test to market. This new study was funded by the U.K.

Sources

  • University of Reading, news release, March 30, 2026
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords